[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368469-105":59,"doc-detail-368469-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","genetic-determinants-and-clinical-significance-of-circulating-and-tumor-specific-levels-of-insulin-like-growth-factor-binding-protein-7-igfbp7-in-a-swedish-breast-cancer-cohort","Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort","","Previous research indicates insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer tissue and blood are prognostic, yet the genetic determinants of IGFBP7 in breast cancer are insufficiently defined. This study analyzed IGFBP7 in a Swedish cohort of 1701 patients with first breast cancer and followed participants up to 15 years. Measurements included tumor-specific protein levels on tissue microarrays and circulating IGFBP7 in plasma, with additional genotype-based proxy markers constructed from candidate SNPs, using regression and Cox models to evaluate associations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetic-determinants-and-clinical-significance-of-circulating-and-tumor-specific-levels-of-insulin-like-growth-factor-binding-protein-7-igfbp7-in-a-swedish-breast-cancer-cohort/368469/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetic-determinants-and-clinical-significance-of-circulating-and-tumor-specific-levels-of-insulin-like-growth-factor-binding-protein-7-igfbp7-in-a-swedish-breast-cancer-cohort/368469.png","ImageObject",300,407,{"name":92,"@type":93},"WPS_1786070896","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What genetic determinants of IGFBP7 were investigated in breast cancer?","Question",{"text":112,"@type":113},"The study constructed a genetic proxy for circulating IGFBP7 levels using five candidate SNPs and assessed how genetically predicted IGFBP7 related to clinical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were tumor-specific and circulating IGFBP7 levels measured?",{"text":117,"@type":113},"Tumor-specific IGFBP7, insulin receptor (InsR), and IGF-I receptor (IGFIR) were assessed on tumor tissue microarrays, while circulating IGFBP7 was measured in plasma for a subset of patients.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the clinical significance of IGFBP7 levels?",{"text":121,"@type":113},"Higher circulating and genetically predicted IGFBP7 levels were associated with increased risk of distant metastasis and all-cause mortality, and both measured and genetically predicted IGFBP7 acted as independent prognostic biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368469,1790876830,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Original Article  \nGenetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort  \nChristopher Godina1,*, Ann H. Rosendahl1, Kelin Gonçalves de Oliveira1,, Somayeh Khazaei1, Sofie Björner1, Karin Jirström2, Karolin Isaksson3, Michael N. Pollak4, Helena Jernström1,*,  \n1Department of Clinical Sciences Lund, Oncology, Lund University Cancer Center/Kamprad, Lund University and Skåne University Hospital, Barngatan 4, SE 221 85 Lund, Sweden  \n2Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University Cancer Center/Kamprad, Lund University, Barngatan 4, SE 221 85 Lund, Sweden  \n3Department of Clinical Sciences Lund, Surgery, Lund University Cancer Center, Lund University and Kristianstad Hospital, JA Hedlundsväg 5, SE 291 33 Kristianstad, Sweden  \n4Lady Davis Institute for Medical Research, Jewish General Hospital, Department of Oncology, McGill University, 3755 Côte Ste-Catherine Road, Montreal, QC H3T 1E2, Quebec, Canada  \n* Corresponding authors. Helena Jernström, Department of Clinical Sciences Lund, Oncology, Lund University Cancer Center/Kamprad, Lund University and Skåne University Hospital, Barngatan 4, SE 221 85 Lund, Sweden. E-mail: [helena.jernstrom@med.lu.se](helena.jernstrom@med.lu.se); Christopher Godina, Department of Clinical Sciences Lund, Oncology, Lund University Cancer Center/Kamprad, Lund University and Skåne University Hospital, Barngatan 4, SE 221 85 Lund, Sweden. E-mail:  \n[christopher.godina@med.lu.se](christopher.godina@med.lu.se)  \nAbstract  \nPrevious research indicates that insulin-like growth factor binding protein 7 (IGFBP7) protein levels in breast cancer tissue and blood are prognostic. However, genetic determinants of IGFBP7 in breast cancer remain largely unexplored. We examined IGFBP7 in a cohort of 1701 patients with first breast cancer from Sweden, enrolled prior to surgery 2002–16 and followed for up to 15 years. Genotyping was performed on blood samples using OncoArray. Tumor-specific protein levels of IGFBP7, insulin receptor (InsR), and IGF-I receptor (IGFIR) were assessed on tumor tissue microarrays in 964 patients. Furthermore, 275 patients had plasma IGFBP7 levels measured. A genetic proxy marker for circulating IGFBP7 levels was constructed from five candidate single-nucleotide polymorphisms (SNPs) (rs6852762, rs1714014, rs9992658, rs10004910, and rs4865180) based on number of recessive genotypes. Age-adjusted linear regression was used to evaluate SNPs and tumor-specific IGFBP7 levels in relation to circulating IGFBP7 levels. Cox regression adjusted for age, tumor characteristics, and adjuvant treatments was used to assess associations with clinical outcomes. Circulating and tumor-specific IGFBP7 levels were significantly positively correlated. High circulating and genetically predicted IGFBP7 levels were associated with increased risk for distant metastasis and all-cause mortality. A significant interaction between high tumor-specific IGFBP7 levels and membrane-bound InsR resulted in a four-fold increased risk of breast cancer events and distant metastases. Both measured and genetically predicted IGFBP7 levels were independent prognostic biomarkers in breast cancer.  \nReceived: October 30 2024; revised: March 11 2025; accepted: April 11 2025 © The Author(s) 2025. Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by-nc/4.0/](licenses/by-nc/4.0/)), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [reprints@oup.com](reprints@oup.com) for reprints and translation rights for reprints. All other permissions can be obtained ","cbCaiiAulAWHzObA","https://ap.wps.com/l/cbCaiiAulAWHzObA","pdf",4274995,15,"English","# Abstract\n## Study design and cohort\n## Genotyping and biomarker assessment\n## Statistical analysis and clinical outcomes","[{\"question\":\"What genetic determinants of IGFBP7 were investigated in breast cancer?\",\"answer\":\"The study constructed a genetic proxy for circulating IGFBP7 levels using five candidate SNPs and assessed how genetically predicted IGFBP7 related to clinical outcomes.\"},{\"question\":\"How were tumor-specific and circulating IGFBP7 levels measured?\",\"answer\":\"Tumor-specific IGFBP7, insulin receptor (InsR), and IGF-I receptor (IGFIR) were assessed on tumor tissue microarrays, while circulating IGFBP7 was measured in plasma for a subset of patients.\"},{\"question\":\"What was the clinical significance of IGFBP7 levels?\",\"answer\":\"Higher circulating and genetically predicted IGFBP7 levels were associated with increased risk of distant metastasis and all-cause mortality, and both measured and genetically predicted IGFBP7 acted as independent prognostic biomarkers.\"}]","Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort | PDF",1790177080,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4287f0eb85deb62d88379ff66ff9cb91.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67200740916bccfa7d3da9aa79f9830a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff8a7c60c02b74491ce0332b9692834a.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad3dbdacbe7db93c938207a94381f5c7.webp",980,1287]